Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells

被引:73
作者
VanRollins, M
Kaduce, TL
Fang, X
Knapp, HR
Spector, AA
机构
[1] UNIV IOWA, COLL MED, DEPT INTERNAL MED, IOWA CITY, IA 52242 USA
[2] UNIV IOWA, COLL MED, DEPT BIOCHEM, IOWA CITY, IA 52242 USA
[3] UNIV IOWA, COLL MED, DEPT PHARMACOL, IOWA CITY, IA 52242 USA
关键词
D O I
10.1074/jbc.271.24.14001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epoxyeicosatrienoic acids (EETs) are synthesized by cytochrome P-450 monooxygenases and released into the blood. When taken up by vascular endothelial and smooth muscle cells, the EETs are primarily esterified to phospholipids or converted to dihydroxyeicosatetraenoic acids (DHETs) and released. In the present studies, radiolabeled 8,9-, 11,12-, and 14,15-DHETs released into the medium from vascular smooth muscle cells were isolated and incubated for 4-16 h with cultured bovine aortic endothelial cells. The uptake ranged from 2 to 50% for the three regioisomers. Hydrolysis of the endothelial lipids and gas chromatographic-mass spectral analyses of the products indicated that all three DHET regioisomers were incorporated intact into phosphatidylcholine and phosphatidylinositol. Similar incubations with EETs confirmed that small amounts of DHETs were also esterified to endothelial phospholipids. These studies indicate that DHETs are incorporated into phospholipids either at the time of EET conversion to DHET or upon release and re-uptake of DHETs. Beside demonstrating for the first time that fatty acid diols are incorporated intact into endothelial lipids, these studies raise the possibility that both EETs and DHETs remain long enough in the vascular wall to produce chronic vasoactive effects.
引用
收藏
页码:14001 / 14009
页数:9
相关论文
共 45 条
[11]  
FOLCH J, 1957, J BIOL CHEM, V226, P497
[12]   DIFFERENTIAL METABOLISM OF HYDROXYEICOSATETRAENOIC ACID ISOMERS BY MOUSE CEREBROMICROVASCULAR ENDOTHELIUM [J].
GIORDANO, MJ ;
MATHUR, SN ;
MOORE, SA .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (01) :374-382
[13]  
GOLDSMITH JC, 1981, LAB INVEST, V45, P191
[14]   ROLE OF CYTOCHROME-P-450 ENZYMES AND METABOLITES OF ARACHIDONIC-ACID IN THE CONTROL OF VASCULAR TONE [J].
HARDER, DR ;
CAMPBELL, WB ;
ROMAN, RJ .
JOURNAL OF VASCULAR RESEARCH, 1995, 32 (02) :79-92
[15]   THE SYNTHESIS AND MOLECULAR-DYNAMICS OF PHOSPHOLIPIDS HAVING HYDROXYLATED FATTY-ACIDS AT THE SN-2 POSITION [J].
ISAACSON, Y ;
SHERBOURNE, CD ;
GROSS, RW ;
STENSON, WF .
CHEMISTRY AND PHYSICS OF LIPIDS, 1990, 52 (3-4) :217-226
[16]   ARACHIDONIC-ACID EPOXYGENASE - STRUCTURAL CHARACTERIZATION AND QUANTIFICATION OF EPOXYEICOSATRIENOATES IN PLASMA [J].
KARARA, A ;
WEI, S ;
SPADY, D ;
SWIFT, L ;
CAPDEVILA, JH ;
FALCK, JR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (03) :1320-1325
[17]  
KNAPP HR, 1991, CLIN RES, V39, pA185
[18]  
LEGRAND AB, 1991, J BIOL CHEM, V266, P7570
[19]   AN EPOXYGENASE METABOLITE OF ARACHIDONIC-ACID MEDIATES ANGIOTENSIN-II-INDUCED RISES IN CYTOSOLIC CALCIUM IN RABBIT PROXIMAL TUBULE EPITHELIAL-CELLS [J].
MADHUN, ZT ;
GOLDTHWAIT, DA ;
MCKAY, D ;
HOPFER, U ;
DOUGLAS, JG .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (02) :456-461
[20]   CYTOCHROME-P-450 METABOLISM OF ARACHIDONIC-ACID [J].
MCGIFF, JC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1991, 31 :339-369